Get Premium to unlock powerful stock data
Avidity Biosciences Inc logo

Avidity Biosciences Inc

$ 14.63 +1.22 (+9.1%) 10:08 PM EST
P/E:
At Loss
P/B:
1.94
Market Cap:
$ 728.04M
Enterprise V:
$ 342.86M
Volume:
372.55K
Avg Vol (2M):
247.21K
Volume:
372.55K
Market Cap $:
728.04M
PE Ratio:
At Loss
Avg Vol (2-Month):
247.21K
Enterprise Value $:
342.86M
PB Ratio:
1.94
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Avidity Biosciences Inc
NAICS : 541714 SIC : 2834
10578 Science Center Drive, Suite 125, San Diego, CA, USA, 92121
Description
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.
Name Current Vs Industry Vs History
Cash-To-Debt 33.39
Equity-to-Asset 0.89
Debt-to-Equity 0.03
Debt-to-EBITDA -0.09
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 8.97
Distress
Grey
Safe
Beneish M-Score -2.69
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 71.3
9-Day RSI 58.6
14-Day RSI 52.31
6-1 Month Momentum % -39.8
12-1 Month Momentum % -39.68

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.09
Quick Ratio 13.09
Cash Ratio 12.84

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -32.2

Financials (Next Earnings Date:2022-08-09 Est.)

RNA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:RNA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 8.417
EPS (TTM) ($) -3.73
Beta 0
Volatility % 51.21
14-Day RSI 52.31
14-Day ATR ($) 1.311386
20-Day SMA ($) 13.404
12-1 Month Momentum % -39.68
52-Week Range ($) 11.02 - 29.59
Shares Outstanding (Mil) 49.76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Avidity Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More